Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Breast Pain and Ultrasound: If Normal Result, Exploring the Uterus is a Good Reflex.

Gabrielle AEP, Hasina RNONL, Honjaniana R, Christian T, Ahmad A.

J Med Ultrasound. 2018 Jan-Mar;26(1):62. doi: 10.4103/JMU.JMU_8_18. Epub 2018 Mar 28. No abstract available.

2.

Genomics of mucoepidermoid and adenoid cystic carcinomas.

Yan K, Yesensky J, Hasina R, Agrawal N.

Laryngoscope Investig Otolaryngol. 2018 Feb 8;3(1):56-61. doi: 10.1002/lio2.139. eCollection 2018 Feb. Review.

3.

Role of dental hardware in oral cavity squamous cell carcinoma in the low-risk nonsmoker nondrinker population.

Yesensky JA, Hasina R, Wroblewski KE, Bellairs J, Gooi Z, Saloura V, Cipriani NA, Vokes EE, Portugal LG, Seiwert TY, Blair ED, Agrawal N.

Head Neck. 2018 Apr;40(4):784-792. doi: 10.1002/hed.25059. Epub 2018 Jan 22.

PMID:
29356169
4.

Tumor DNA: an emerging biomarker in head and neck cancer.

Bellairs JA, Hasina R, Agrawal N.

Cancer Metastasis Rev. 2017 Sep;36(3):515-523. doi: 10.1007/s10555-017-9685-x. Review.

PMID:
28801876
5.

Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma.

Rolle CE, Tan YC, Seiwert TY, Vora S, Kanteti R, Hasina R, Carey GB, Surati M, Weichselbaum RR, Lingen MW, Vokes EE, Salgia R.

Oncotarget. 2017 Mar 21;8(12):18726-18734. doi: 10.18632/oncotarget.9640.

6.

Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.

Khammanivong A, Sorenson BS, Ross KF, Dickerson EB, Hasina R, Lingen MW, Herzberg MC.

Oncotarget. 2016 Mar 22;7(12):14029-47. doi: 10.18632/oncotarget.7373.

7.

[Intestinal parasites simulating appendicitis on ultrasound: about two cases].

Gabrielle AE, Hasina RN, Ravelonarivo R, Ahmad A.

Pan Afr Med J. 2015 Aug 31;21:322. doi: 10.11604/pamj.2015.21.322.3339. eCollection 2015. French. No abstract available.

8.

[Goiter on pre-sternal thyroid dysgenesis].

Fanantenana HN, Hasina RN, Hery R, Claude RA, Ahmad A.

Pan Afr Med J. 2015 Jun 12;21:117. doi: 10.11604/pamj.2015.21.117.6919. eCollection 2015. French. No abstract available.

9.

MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma.

Kanteti R, Dhanasingh I, Kawada I, Lennon FE, Arif Q, Bueno R, Hasina R, Husain AN, Vigneswaran W, Seiwert T, Kindler HL, Salgia R.

PLoS One. 2014 Sep 15;9(9):e105919. doi: 10.1371/journal.pone.0105919. eCollection 2014.

10.

Increased μ-opioid receptor expression in metastatic lung cancer.

Singleton PA, Mirzapoiazova T, Hasina R, Salgia R, Moss J.

Br J Anaesth. 2014 Jul;113 Suppl 1:i103-8. doi: 10.1093/bja/aeu165. Epub 2014 Jun 11.

11.

O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer.

Hasina R, Surati M, Kawada I, Arif Q, Carey GB, Kanteti R, Husain AN, Ferguson MK, Vokes EE, Villaflor VM, Salgia R.

J Carcinog. 2013 Oct 28;12:20. doi: 10.4103/1477-3163.120632. eCollection 2013.

12.

Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.

Kawada I, Hasina R, Arif Q, Mueller J, Smithberger E, Husain AN, Vokes EE, Salgia R.

Cancer Res. 2014 Feb 1;74(3):884-95. doi: 10.1158/0008-5472.CAN-12-3583. Epub 2013 Dec 4.

13.

The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.

Ferguson BD, Liu R, Rolle CE, Tan YH, Krasnoperov V, Kanteti R, Tretiakova MS, Cervantes GM, Hasina R, Hseu RD, Iafrate AJ, Karrison T, Ferguson MK, Husain AN, Faoro L, Vokes EE, Gill PS, Salgia R.

PLoS One. 2013 Jul 2;8(7):e67668. doi: 10.1371/journal.pone.0067668. Print 2013.

14.

Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer.

Kawada I, Hasina R, Lennon FE, Bindokas VP, Usatyuk P, Tan YH, Krishnaswamy S, Arif Q, Carey G, Hseu RD, Robinson M, Tretiakova M, Brand TM, Iida M, Ferguson MK, Wheeler DL, Husain AN, Natarajan V, Vokes EE, Singleton PA, Salgia R.

Cancer Biol Ther. 2013 Jul;14(7):679-91. doi: 10.4161/cbt.25091. Epub 2013 May 31.

15.

Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers.

Hasina R, Mollberg N, Kawada I, Mutreja K, Kanade G, Yala S, Surati M, Liu R, Li X, Zhou Y, Ferguson BD, Nallasura V, Cohen KS, Hyjek E, Mueller J, Kanteti R, El Hashani E, Kane D, Shimada Y, Lingen MW, Husain AN, Posner MC, Waxman I, Villaflor VM, Ferguson MK, Varticovski L, Vokes EE, Gill P, Salgia R.

Cancer Res. 2013 Jan 1;73(1):184-94. doi: 10.1158/0008-5472.CAN-12-0915. Epub 2012 Oct 24. Erratum in: Cancer Res. 2013 Jul 15;73(14):4594.

16.

The role of the c-Met pathway in lung cancer and the potential for targeted therapy.

Sattler M, Reddy MM, Hasina R, Gangadhar T, Salgia R.

Ther Adv Med Oncol. 2011 Jul;3(4):171-84. doi: 10.1177/1758834011408636.

17.

Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.

Surati M, Robinson M, Nandi S, Faoro L, Demchuk C, Rolle CE, Kanteti R, Ferguson BD, Hasina R, Gangadhar TC, Salama AK, Arif Q, Kirchner C, Mendonca E, Campbell N, Limvorasak S, Villaflor V, Hensing TA, Krausz T, Vokes EE, Husain AN, Ferguson MK, Karrison TG, Salgia R.

J Clin Bioinforma. 2011 Feb 28;1(8):1-11. doi: 10.1186/2043-9113-1-8.

18.

RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.

Catenacci DV, Cervantes G, Yala S, Nelson EA, El-Hashani E, Kanteti R, El Dinali M, Hasina R, Brägelmann J, Seiwert T, Sanicola M, Henderson L, Grushko TA, Olopade O, Karrison T, Bang YJ, Kim WH, Tretiakova M, Vokes E, Frank DA, Kindler HL, Huet H, Salgia R.

Cancer Biol Ther. 2011 Jul 1;12(1):9-46. doi: 10.4161/cbt.12.1.15747. Epub 2011 Jul 1.

19.

Generation of comprehensive thoracic oncology database--tool for translational research.

Surati M, Robinson M, Nandi S, Faoro L, Demchuk C, Kanteti R, Ferguson B, Gangadhar T, Hensing T, Hasina R, Husain A, Ferguson M, Karrison T, Salgia R.

J Vis Exp. 2011 Jan 22;(47). pii: 2414. doi: 10.3791/2414.

20.

Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis.

Zhou G, Hasina R, Wroblewski K, Mankame TP, Doçi CL, Lingen MW.

Cancer Prev Res (Phila). 2010 Nov;3(11):1493-502. doi: 10.1158/1940-6207.CAPR-10-0135. Epub 2010 Oct 26.

21.

Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis.

Lee Y, Yang X, Huang Y, Fan H, Zhang Q, Wu Y, Li J, Hasina R, Cheng C, Lingen MW, Gerstein MB, Weichselbaum RR, Xing HR, Lussier YA.

PLoS Comput Biol. 2010 Apr 1;6(4):e1000730. doi: 10.1371/journal.pcbi.1000730.

22.

CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases.

Tan YH, Krishnaswamy S, Nandi S, Kanteti R, Vora S, Onel K, Hasina R, Lo FY, El-Hashani E, Cervantes G, Robinson M, Hsu HS, Kales SC, Lipkowitz S, Karrison T, Sattler M, Vokes EE, Wang YC, Salgia R.

PLoS One. 2010 Jan 29;5(1):e8972. doi: 10.1371/journal.pone.0008972. Erratum in: PLoS One. 2011;6(1). doi: 10.1371/annotation/940edb14-522e-4f38-b6c4-7557e9a13d15. Hsu, Han-Shui [added].

23.

ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis.

Hasina R, Martin LE, Kasza K, Jones CL, Jalil A, Lingen MW.

Cancer Prev Res (Phila). 2009 Apr;2(4):385-93. doi: 10.1158/1940-6207.CAPR-08-0211. Epub 2009 Mar 31.

24.

Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications.

Hasina R, Whipple ME, Martin LE, Kuo WP, Ohno-Machado L, Lingen MW.

Lab Invest. 2008 Apr;88(4):342-53. doi: 10.1038/labinvest.2008.6. Epub 2008 Feb 18.

25.

NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype.

Hasina R, Pontier AL, Fekete MJ, Martin LE, Qi XM, Brigaudeau C, Pramanik R, Cline EI, Coignet LJ, Lingen MW.

Oncogene. 2006 Jan 26;25(4):588-98.

PMID:
16205646
26.

Head and neck cancer: the pursuit of molecular diagnostic markers.

Hasina R, Lingen MW.

Semin Oncol. 2004 Dec;31(6):718-25. Review.

PMID:
15599849
27.

Classification and identification of genes associated with oral cancer based on gene expression profiles. A preliminary study.

Kuo WP, Hasina R, Ohno-Machado L, Lingen MW.

N Y State Dent J. 2003 Feb;69(2):23-6.

PMID:
12703240
28.

Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.

Hasina R, Hulett K, Bicciato S, Di Bello C, Petruzzelli GJ, Lingen MW.

Cancer Res. 2003 Feb 1;63(3):555-9.

29.

Gene expression levels in different stages of progression in oral squamous cell carcinoma.

Kuo WP, Jenssen TK, Park PJ, Lingen MW, Hasina R, Ohno-Machado L.

Proc AMIA Symp. 2002:415-9.

31.

Angiogenesis in oral cancer.

Hasina R, Lingen MW.

J Dent Educ. 2001 Nov;65(11):1282-90. Review.

32.

Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages.

Liss C, Fekete MJ, Hasina R, Lam CD, Lingen MW.

Int J Cancer. 2001 Sep;93(6):781-5.

33.

Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line.

Hasina R, Matsumoto K, Matsumoto-Taniura N, Kato I, Sakuda M, Nakamura T.

Br J Cancer. 1999 Aug;80(11):1708-17.

Supplemental Content

Loading ...
Support Center